Rankings
▼
Calendar
ZTS Q4 2016 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.3B
Gross Profit
$790M
61.9% margin
Operating Income
$321M
25.1% margin
Net Income
$154M
12.1% margin
EPS (Diluted)
$0.31
QoQ Revenue Growth
+2.9%
Cash Flow
Operating Cash Flow
$286M
Free Cash Flow
$226M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$7.6B
Total Liabilities
$6.2B
Stockholders' Equity
$1.5B
Cash & Equivalents
$727M
Revenue Segments
Cattle
$478M
37%
Dogs and Cats
$435M
34%
Swine
$161M
13%
Poultry
$106M
8%
Sheep and Other
$57M
4%
Horses
$42M
3%
Geographic Segments
International Segment
$636M
50%
United States Segment
$631M
50%
← FY 2016
All Quarters
Q1 2017 →